Exploring the Link Between SARS-CoV-2 Infection, GnRH Loss, and Long-Term Cognitive Decline


The cognitive decline associated with age-related dementias is a growing concern in aging societies, affecting millions worldwide.

Recent groundbreaking research has shed light on a potential link between the progressive loss of gonadotropin-releasing hormone (GnRH) expression and cognitive deficits in individuals with Down syndrome (DS) and a trisomic animal model of DS.

This research suggests that GnRH, long considered solely a hormone for regulating the reproductive axis, might play a crucial role in cognitive function. Moreover, this link between GnRH and cognition extends to mouse models of Alzheimer’s disease (AD) and is mirrored in the known association between gonadotropin levels and altered cognitive function in menopause, andropause, or aging.

These findings raise the intriguing possibility that GnRH insufficiency due to age or disease could be a common mechanism underlying various forms of age-related cognitive decline.

Adding to this complexity, COVID-19 infection has been associated with accelerated aging and an increased risk of neurodegenerative conditions, such as Alzheimer’s disease, in affected patients. Additionally, “long COVID,” characterized by persistent symptoms even after the acute infection has resolved, presents a significant concern for healthcare and the economy.

Many long COVID patients report cognitive difficulties, fatigue, headaches, and anosmia (loss of smell), symptoms that resemble reports of neuroinvasion by the SARS-CoV-2 virus.

Interestingly, a significant proportion of male COVID-19 patients also exhibit low testosterone levels, reminiscent of GnRH-related dysfunction in the hypothalamic-pituitary-gonadal (HPG) axis.

In this article, we delve into a groundbreaking study that explores the potential link between SARS-CoV-2 infection, GnRH loss, and long-term cognitive decline. We examine how GnRH neurons are affected by SARS-CoV-2, discuss the consequences of this interaction on cognitive function, energy metabolism, and reproduction, and consider the implications for neonates born to infected mothers.

SARS-CoV-2 Neuroinvasion: A Multi-Pronged Approach

Evidence of SARS-CoV-2’s impact on the brain is mounting, though not all regions may be equally vulnerable. Recent studies have indicated that olfactory sensory neurons in the nasal epithelium of COVID-19 patients can be infected by the virus, providing a plausible route for viral entry into the brain via olfactory and terminal nerves.

Furthermore, SARS-CoV-2 particles in the bloodstream can potentially infiltrate the brain by bypassing the blood-brain barrier, particularly in the fenestrated vessels of circumventricular organs.

Interestingly, the median eminence in the hypothalamus, a region devoid of the traditional blood-brain barrier, might represent a breach in the brain’s defenses against pathogens. Additionally, endothelial cells forming the blood-brain barrier can be infected by SARS-CoV-2, further increasing the likelihood of viral entry into the brain. Given that GnRH neurons have connections to both the nasal epithelium, where they originate, and the perivascular space around fenestrated vessels in the median eminence, they are susceptible to infection via multiple routes.

The Impact of GnRH Loss in COVID-19

The infection of GnRH neurons or tanycytes, which interact with GnRH terminals, may result in hypogonadotropic hypogonadism due to decreased GnRH expression or impaired secretion. Importantly, GnRH neurons in COVID-19 patients were not only affected but also exhibited signs of cell death, suggesting a potential long-term decline in GnRH production.

This loss of GnRH could have several significant consequences:

  • Fertility Impairment: Reduced GnRH expression may lead to delayed fertility in both male and female COVID-19 survivors, a concern given the global decline in human fertility.
  • Olfactory Deficits: COVID-19 patients often experience anosmia or dysosmia, which may be linked to GnRH loss, as GnRH plays a role in olfactory perception.
  • Cognitive Decline: GnRH neurons project to brain regions involved in cognition, such as the cortex and hippocampus. The loss of GnRH expression and neurons may contribute to age-related cognitive decline, which is exacerbated by SARS-CoV-2 infection.
  • Energy Metabolism Disruption: GnRH neurons also play a role in regulating energy metabolism, and their loss may contribute to metabolic disturbances, potentially explaining the increased risk of diabetes observed in COVID-19 survivors.

Maternal and Neonatal Considerations

Pregnant women infected with SARS-CoV-2 may transmit the virus to their neonates, raising concerns about the potential consequences of neonatal exposure. The timing is crucial because the first postnatal activation of the HPG axis, known as minipuberty, occurs shortly after birth and is critical for reproductive system maturation and broader brain development. Impairments during minipuberty may be linked to various age-related non-communicable diseases or metabolic dysfunctions later in life.


The study’s findings highlight the urgency of conducting longitudinal studies on COVID-19 survivors to understand the long-term effects of SARS-CoV-2 infection. These effects may encompass developmental, reproductive, metabolic, and cognitive disorders, with GnRH loss emerging as a potential underlying mechanism. Such research is crucial for developing strategies to mitigate the impact of the ongoing pandemic on well-aging and public health.

In conclusion, the intricate relationship between SARS-CoV-2, GnRH, and long-term cognitive decline underscores the need for further investigation and vigilant monitoring of affected individuals. It also prompts consideration of potential therapeutic interventions, such as GnRH replacement therapy, to address the multifaceted consequences of this novel virus on human health and aging.

in deep…

Low testosterone levels in male COVID-19 patients: A detailed review

Testosterone is a sex hormone that plays a vital role in male health and development. It is responsible for a range of functions, including muscle mass and strength, bone density, libido, and sperm production.

Interestingly, a significant proportion of male COVID-19 patients also exhibit low testosterone levels. This has led researchers to investigate the link between COVID-19 and the hypothalamic-pituitary-gonadal (HPG) axis, which is the system that regulates testosterone production.

The HPG axis

The HPG axis is a complex system that involves three main glands: the hypothalamus, the pituitary gland, and the testes.

The hypothalamus produces gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH then travel to the testes, where they stimulate the production of testosterone and sperm.

COVID-19 and the HPG axis

There are a number of ways in which COVID-19 could affect the HPG axis.

One possibility is that the virus could directly infect the hypothalamus, pituitary gland, or testes. This could damage the cells in these glands and disrupt the production of GnRH, LH, FSH, and testosterone.

Another possibility is that COVID-19 could trigger an inflammation response throughout the body. This inflammation could damage the cells in the HPG axis and disrupt their function.

In addition, COVID-19 can cause a number of other medical problems, such as pneumonia, acute respiratory distress syndrome, and sepsis. These problems can lead to a decrease in testosterone levels.

Several potential mechanisms have been proposed to explain the observed reduction in testosterone levels in COVID-19 patients:

  • Direct Viral Infection: SARS-CoV-2 may directly infect testicular cells, disrupting their function and reducing testosterone production. This is supported by the presence of ACE2 receptors, which the virus uses for cell entry, in the testes.
  • Systemic Inflammation: COVID-19 triggers a robust immune response, leading to systemic inflammation. Inflammation in the testes, known as orchitis, can impair Leydig cell function, responsible for testosterone production.
  • Hypoxia: Severe COVID-19 cases often involve respiratory distress and reduced oxygen levels (hypoxia). Hypoxia can negatively impact testicular function and hormone production.
  • Medications: Some medications used in COVID-19 treatment, such as corticosteroids, have been associated with reduced testosterone levels.

Understanding the link between COVID-19 and low testosterone levels has important clinical implications:

  • Reproductive Health: Reduced testosterone levels can impact fertility and sexual function in male patients. Monitoring and managing testosterone levels in COVID-19 patients may be crucial for long-term reproductive health.
  • Muscle Mass and Bone Health: Testosterone is essential for maintaining muscle mass and bone density. Low levels may lead to muscle wasting and increased fracture risk.
  • Immune Function: Testosterone plays a role in immune regulation. Its reduction may affect the body’s ability to mount an effective immune response.
  • Psychological Health: Low testosterone levels are associated with mood disturbances and depression. Monitoring mental health is important for COVID-19 survivors.

Clinical implications

Low testosterone levels can have a number of negative consequences for male health, including:

  • Decreased muscle mass and strength
  • Decreased bone density
  • Reduced libido
  • Erectile dysfunction
  • Infertility
  • Fatigue
  • Depression

In addition, low testosterone levels have been linked to an increased risk of cardiovascular disease, stroke, and death.


The link between COVID-19 and low testosterone levels is still an area of active research. However, it is clear that the virus can have a negative impact on the HPG axis and testosterone production.

For male patients who have been diagnosed with COVID-19, it is important to monitor their testosterone levels and seek treatment if necessary. Testosterone replacement therapy can be an effective way to improve testosterone levels and reduce the symptoms of low testosterone.

Additional details

In addition to the information above, here are some additional details about the link between COVID-19 and low testosterone levels:

  • Studies have shown that male patients with COVID-19 have significantly lower testosterone levels than healthy men.
  • The severity of COVID-19 appears to be correlated with testosterone levels. Men with more severe cases of COVID-19 tend to have lower testosterone levels.
  • Low testosterone levels have been associated with an increased risk of death from COVID-19.
  • Testosterone replacement therapy has been shown to improve outcomes in male patients with COVID-19.

Future research

More research is needed to understand the exact mechanisms by which COVID-19 affects the HPG axis and testosterone production. Additionally, more research is needed to develop effective treatments for low testosterone levels in male COVID-19 patients.


Low testosterone levels are a common finding in male COVID-19 patients. The virus can affect the HPG axis in a number of ways, leading to a decrease in testosterone production. Low testosterone levels can have a number of negative consequences for male health, including decreased muscle mass and strength, reduced libido, erectile dysfunction, infertility, fatigue, and depression.

For male patients who have been diagnosed with COVID-19, it is important to monitor their testosterone levels and seek treatment if necessary. Testosterone replacement therapy can be an effective way to improve testosterone levels and reduce the symptoms of low testosterone.



Please enter your comment!
Please enter your name here

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.